Jun 7, 2023, 3:14 PM EDT
Conservatives call out multinational corporations for supporting pride month in America, but not Middle East
Conservatives on Twitter are calling out multinational corporations for displaying a pride flag-theamed logo on American social media accounts, but not for those overseas.
Poland asks Pfizer to renegotiate COVID-19 vaccine deal
Poland has called on Pfizer to come to more favorable terms in negotiations to lower the total amount of COVID-19 doses it is sending.
Where to invest your money in 2023 after rough year-end in the markets
University of San Diego finance professor Dan Roccato shared some market insights and investing tips for the New Year of 2023 on "Fox & Friends" on Monday.
China approves sale of Pfizer COVID pill Paxlovid as cases surge, White House denies involvement
The White House says it was not in any way involved in China's approval of Pfizer's COVID-19 pill to treat an anticipated wave of infections.
DeSantis calls for Florida grand jury to investigate coronavirus vaccine 'wrongdoing'
Florida Gov. Ron DeSantis, during a panel about reported side effects of coronavirus vaccines, says he wants a statewide grand jury to investigate any "wrongdoing" surrounding them.
Pfizer develops RSV vaccine for infants given during pregnancy
Pfizer announced an experimental vaccine that, when administered during pregnancy, would protect infants from severe illness for up to six months of life.
Pfizer to supply up to 6 million courses of COVID-19 treatment for lower income countries
Pfizer plans to provide millions of COVID-19 treatment courses for lower income countries. Access to Paxlovid treatment courses has been severely restricted to poorer countries.
China approves Livzon Pharmaceutical's COVID vaccine as a booster
With COVID cases on the rise in China, the government has approved Livzon Pharmaceutical's COVID-19 vaccine as a booster, in hopes of having as many people boosted as possible.
CDC approves updated COVID-19 vaccines targeting omicron variant
The Centers for Disease Control and Prevention gave final approval to updated COVID-19 vaccines targeting the dominant omicron variant on Thursday.
Pfizer offers 'Breakthrough Fellowship Program' that excludes Asian and White applicants
Pfizer is offering a fellowship program specifically for “early career colleagues of Black/African American, Latino/Hispanic and Native American descent."